The mouse mammary tumor virus (MMTV)-neu (Her2) line was used to model Her2-amplified (Her2+) breast cancer, a subtype representing approximately 17% of breast cancer patients15,16. This evidence concerns the gene ERBB2 and breast carcinoma.